Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 6/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.36 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP3 | P08254 | 1/20 | 0.35 |
| ▸ | MMP7 | P09237 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
| ▸ | MMP12 | P39900 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E637 SCHEMBL41817 | 1.00 | KDM4E (0.55) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL23309786 | 0.98 | KDM4E (0.53) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL27635951 | 0.98 | KDM4E (0.53) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL6657728 | 0.98 | KDM4E (0.53) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL8026696 | 0.98 | KDM4E (0.53) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL14990891 | 0.93 | KDM4E (0.48) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL290806 | 0.91 | LMNA (0.72) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL11019418 | 0.89 | LMNA (0.70) | KDM4ELMNAAPPMAPK1FTO | |
| SCHEMBL9625161 | 0.84 | KDM4E (0.52) | KDM4ELMNAAPPMAPK1FTO | |
| SCHEMBL9625506 | 0.81 | KDM4E (0.48) | KDM4ELMNAAPPALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11062794-B2 | Olfactory signature and odorant mixture having the same | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-07-13 | — | — | US | disclosed |
| EP-3416728-A1 | METHODS OF FORMING A SLURRY WITH MICROCAPSULES FORMED FROM PHOSPHATE ESTERS AND MULTIVALENT IONS | The Procter and Gamble Company (US) | 2018-12-26 | — | — | EP | disclosed |
| EP-3399960-A1 | ANTIPERSPIRANT COMPOSITION | The Procter and Gamble Company (US) | 2018-11-14 | — | — | EP | disclosed |
| US-20180253534-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2018-09-06 | — | — | US | disclosed |
| EP-3250179-A1 | STARCH BENEFIT AGENT DELIVERY VEHICLE | The Procter and Gamble Company (US) | 2017-12-06 | — | — | EP | disclosed |
| WO-2017120152-A1 | ANTIPERSPIRANT COMPOSITION | THE PROCTER & GAMBLE COMPANY (US) | 2017-07-13 | — | — | WO | disclosed |
| WO-2017120149-A1 | STARCH BENEFIT AGENT DELIVERY VEHICLE | THE PROCTER & GAMBLE COMPANY (US) | 2017-07-13 | — | — | WO | disclosed |
| WO-2017120151-A1 | METHODS OF FORMING A SLURRY WITH MICROCAPSULES FORMED FROM PHOSPHATE ESTERS AND MULTIVALENT IONS | THE PROCTER & GAMBLE COMPANY (US) | 2017-07-13 | — | — | WO | disclosed |
| EP-2496682-A1 | DELIVERY PARTICLE | The Procter & Gamble Company (US) | 2012-09-12 | — | — | EP | disclosed |
| WO-2011056935-A1 | DELIVERY PARTICLE | THE PROCTER & GAMBLE COMPANY (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20090257973-A1 | MALODOR REDUCING COMPOSITION, FRAGRANCE COMPOSITION AND PRODUCT COMPRISING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090257973-A1 | MALODOR REDUCING COMPOSITION, FRAGRANCE COMPOSITION AND PRODUCT COMPRISING THE SAME | AKR1C4, AKR1C3, AKR1C1 | KDM4E 287/4885LMNA 1684/4885APP 2514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.